IBRX ImmunityBio Inc: Multiplikator nilai perusahaan marang pendapatan

Logo perusahaan publik immunitybio.com (IBRX)

ImmunityBio, Inc. (IBRX) generates revenue through the commercial implementation of ANKTIVA therapy for the treatment of bladder cancer. Clinics and insurance funds provide cash inflows via payments for this innovative treatment. Upgraded bioreactors at the company's own plants guarantee the production of large volumes. The total cost-to-revenue ratio reflects the impact of monetary policy, with 44313.14 recorded as the baseline value.

Nilai perusahaan marang pendapatan: ImmunityBio Inc (IBRX) kanggo 23.11.2025 - 19.11.2026

immunitybio.com - rincian analitis lan metrik utama (IBRX)

- rega saham lan konsensus proyeksi valuasi:
Analisis wiwitan perusahaan:ImmunityBio, Inc. IBRX
Sampel barang ImmunityBio, Inc.

For an investor in ImmunityBio, Inc. (IBRX), a leader in T-cell activation for cancer therapy, this indicator serves as a tool to compare market capitalization with actual sales volume. By analyzing the EV/Sales multiple history, which accounts for net debt, one can assess the premium the market currently prices in for the company's breakthrough bladder cancer treatment technologies relative to its generated revenue.

Analisis pesaing ImmunityBio, Inc.

IMCR (immunocore.com) - Rasio nilai perusahaan marang pendapatan|Janux Corp (JANX) - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Arcus Bio (RCUS)|Nilai perusahaan marang pendapatan ZYME|TNGX - Rasio nilai perusahaan marang dodolan|Nilai perusahaan marang pendapatan IOVA (Iovance)|Koefisien nilai perusahaan marang pendapatan IMTX|Multiplikator EV/Sales XNCR (Xencor)|Nilai bisnis marang pendapatan CMPX|replimune.com - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Lyell Pharma|Innate Pharma S.A. (IPHA) - Rasio nilai perusahaan marang pendapatan|Pyxis Oncology Inc. - Nilai bisnis marang pendapatan|CGEN (Compugen Limited) - Multiplikator EV/Sales|Multiplikator EV/Sales IO Biotech Inc|Rasio nilai perusahaan marang pendapatan Sutro Biopharma (STRO)|INKT: Nilai perusahaan marang volume dodolan|Werewolf Therapeutics, Inc. - Nilai perusahaan marang pendapatan|Immix (IMMX) - Multiplikator nilai perusahaan marang pendapatan|ALX Oncology Holdings Inc. - Multiplikator EV/Sales|CUE - Multiplikator EV/Sales|PDSB: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Sonnet BioTherapeutics Holdings Inc. (SONN)|MAIA (MAIABiotech.com) - Multiplikator EV/Sales|Nilai perusahaan marang pendapatan Liminatus Pharma (LIMN)|Multiplikator EV/Sales LVTX|Koefisien nilai perusahaan marang pendapatan NXTC|Leap Therapeutics, Inc. - Nilai perusahaan marang pendapatan|INTS: Rasio nilai perusahaan marang pendapatan|Sensei Biotherapeutics Inc - Multiplikator EV/Sales|TOVX: Rasio nilai perusahaan marang pendapatan|gritstonebio.com (GRTS) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan KA|Rasio nilai perusahaan marang pendapatan NexImmune, Inc.|Rasio nilai perusahaan marang pendapatan TSBX (Turnstone Biologics)|Nilai perusahaan marang pendapatan VCNX (Vaccinex, Inc.)|Koefisien nilai perusahaan marang pendapatan HARP